Frontiers Pelotonia Special Edition 2018
The Director's Perspective
Here we are in 2018, the year to celebrate the 10th anniversary of Pelotonia, the annual grassroots cycling event that raises money for cancer research at Ohio State.
More importantly, we can celebrate what Pelotonia has enabled us to accomplish during this first decade. With federal cancer research funding difficult to obtain, you have stepped up through Pelotonia as riders, virtual riders and donors and, as of Sept. 6, raised more than $173 million since 2009. Here are examples of what we have accomplished together:
Pelotonia funds supported basic and clinical research at Ohio State that led to the approval of ibrutinib by the U.S. Food and Drug Administration. This remarkable drug is now available to thousands for the treatment of chronic lymphocytic leukemia.
The Ohio Colorectal Cancer Prevention Initiative (OCCPI) established a statewide network of 50 hospitals to screen newly diagnosed colorectal cancer patients and their biological relatives for an inherited condition that predisposes someone to colorectal, uterine and other cancers.
Beating Lung Cancer in Ohio (BLCIO) is an Ohio-wide study to evaluate the effects of advanced gene testing and expert advice on lung cancer treatment and patient survival, smoking-cessation rates and quality of life.
Ohio Prevention and Treatment of Endometrial Cancer (OPTEC) is a statewide initiative to identify women with uterine cancer whose genetic makeup places them at risk for other types of cancer, and to help match women with uterine cancer to the best treatment.
Pelotonia funds helped establish Ohio State’s Drug Development Institute to accelerate the translation of OSUCCC – James discoveries into new cancer treatments.
Ohio State has a growing digital archive of pathology specimens that is available to cancer investigators worldwide.
The OSUCCC – James co-founded and co-anchors the Oncology Research Information Exchange Network (ORIEN), a collaboration of 18 cancer centers that is speeding the development and delivery of more precise treatments, diagnostic tools and prevention strategies.
The Pelotonia Fellowship Program provides grants to promising undergraduate, graduate, professional and postdoctoral students for conducting cancer research in the labs of faculty mentors.
Pelotonia funds helped support clinical trials that seek better ways to prevent, detect and treat a variety of cancers.
I am grateful to all who play a part in Pelotonia. We look forward to experiencing this great event with you for decades to come and to all that we will accomplish together.
Raphael Pollock, MD, PhD
Director, The Ohio State University Comprehensive Cancer Center